 | • レポートコード：QYR9ST04958 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、多発性硬化症の世界市場について調査・分析し、多発性硬化症の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（注射剤、経口剤）、用途別（病院、研究）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の多発性硬化症市場動向 ・主要企業別マーケットシェア ・多発性硬化症の種類別市場規模2014-2019 （注射剤、経口剤） ・多発性硬化症の用途別市場規模2014-2019 （病院、研究） ・多発性硬化症の北米市場：主要企業・種類別/用途別市場規模 ・多発性硬化症のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・多発性硬化症の中国市場：主要企業・種類別/用途別市場規模 ・多発性硬化症の日本国内市場：主要企業・種類別/用途別市場規模 ・多発性硬化症の東南アジア市場：主要企業・種類別/用途別市場規模 ・多発性硬化症のインド市場：主要企業・種類別/用途別市場規模 ・多発性硬化症の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Abbvie、Acorda Therapeutics、Bayer HealthCare、Biogen、Genzyme (Sanofi)、GlaxoSmithKline、Merck Serono、Novartis、Pfizer、Teva） ・多発性硬化症の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Multiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neurons within the CNS and damages the myelin sheath. It is a potentially debilitating disease, causing disruption in the communication and coordination functions of the body. The symptoms of multiple sclerosis differ widely, subject to the extent of damage and the number of neurons affected. Some of the symptoms observed are fatigue, numbness, spasticity, bladder dysfunction, cognitive changes, emotional changes, and depression. An individual with severe form of the disease can experience speech and movement problems. Nevertheless, the leading pharmaceutical companies operating in North America and Europe is shifting the focus on Asia-pacific region due to the growing demand for effective and economic MS treatment. . Pharmaceutical companies belong to developed regions are focusing on the commercialization of novel therapeutics having minimal side effects and economic pricing. Such product launch strategy would provide an opportunity for the pharmaceutical companies across developing economies. Furthermore, the market is majorly supplemented by increasing funding from government authorities for research and development.
In 2018, the global Multiple Sclerosis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Multiple Sclerosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Multiple Sclerosis development in United States, Europe and China.
The key players covered in this study
Abbvie
Acorda Therapeutics
Bayer HealthCare
Biogen
Genzyme (Sanofi)
GlaxoSmithKline
Merck Serono
Novartis
Pfizer
Teva
Market segment by Type, the product can be split into
Injectable agents
Oral agents
Market segment by Application, split into
Hosptial
Research
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Multiple Sclerosis status, future forecast, growth opportunity, key market and key players.
To present the Multiple Sclerosis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Multiple Sclerosis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Multiple Sclerosis Market Size Growth Rate by Type (2014-2025)
1.4.2 Injectable agents
1.4.3 Oral agents
1.5 Market by Application
1.5.1 Global Multiple Sclerosis Market Share by Application (2014-2025)
1.5.2 Hosptial
1.5.3 Research
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Multiple Sclerosis Market Size
2.2 Multiple Sclerosis Growth Trends by Regions
2.2.1 Multiple Sclerosis Market Size by Regions (2014-2025)
2.2.2 Multiple Sclerosis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Multiple Sclerosis Market Size by Manufacturers
3.1.1 Global Multiple Sclerosis Revenue by Manufacturers (2014-2019)
3.1.2 Global Multiple Sclerosis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Multiple Sclerosis Market Concentration Ratio (CR5 and HHI)
3.2 Multiple Sclerosis Key Players Head office and Area Served
3.3 Key Players Multiple Sclerosis Product/Solution/Service
3.4 Date of Enter into Multiple Sclerosis Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Multiple Sclerosis Market Size by Type (2014-2019)
4.2 Global Multiple Sclerosis Market Size by Application (2014-2019)
5 United States
5.1 United States Multiple Sclerosis Market Size (2014-2019)
5.2 Multiple Sclerosis Key Players in United States
5.3 United States Multiple Sclerosis Market Size by Type
5.4 United States Multiple Sclerosis Market Size by Application
6 Europe
6.1 Europe Multiple Sclerosis Market Size (2014-2019)
6.2 Multiple Sclerosis Key Players in Europe
6.3 Europe Multiple Sclerosis Market Size by Type
6.4 Europe Multiple Sclerosis Market Size by Application
7 China
7.1 China Multiple Sclerosis Market Size (2014-2019)
7.2 Multiple Sclerosis Key Players in China
7.3 China Multiple Sclerosis Market Size by Type
7.4 China Multiple Sclerosis Market Size by Application
8 Japan
8.1 Japan Multiple Sclerosis Market Size (2014-2019)
8.2 Multiple Sclerosis Key Players in Japan
8.3 Japan Multiple Sclerosis Market Size by Type
8.4 Japan Multiple Sclerosis Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Multiple Sclerosis Market Size (2014-2019)
9.2 Multiple Sclerosis Key Players in Southeast Asia
9.3 Southeast Asia Multiple Sclerosis Market Size by Type
9.4 Southeast Asia Multiple Sclerosis Market Size by Application
10 India
10.1 India Multiple Sclerosis Market Size (2014-2019)
10.2 Multiple Sclerosis Key Players in India
10.3 India Multiple Sclerosis Market Size by Type
10.4 India Multiple Sclerosis Market Size by Application
11 Central & South America
11.1 Central & South America Multiple Sclerosis Market Size (2014-2019)
11.2 Multiple Sclerosis Key Players in Central & South America
11.3 Central & South America Multiple Sclerosis Market Size by Type
11.4 Central & South America Multiple Sclerosis Market Size by Application
12 International Players Profiles
12.1 Abbvie
12.1.1 Abbvie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Multiple Sclerosis Introduction
12.1.4 Abbvie Revenue in Multiple Sclerosis Business (2014-2019)
12.1.5 Abbvie Recent Development
12.2 Acorda Therapeutics
12.2.1 Acorda Therapeutics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Multiple Sclerosis Introduction
12.2.4 Acorda Therapeutics Revenue in Multiple Sclerosis Business (2014-2019)
12.2.5 Acorda Therapeutics Recent Development
12.3 Bayer HealthCare
12.3.1 Bayer HealthCare Company Details
12.3.2 Company Description and Business Overview
12.3.3 Multiple Sclerosis Introduction
12.3.4 Bayer HealthCare Revenue in Multiple Sclerosis Business (2014-2019)
12.3.5 Bayer HealthCare Recent Development
12.4 Biogen
12.4.1 Biogen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Multiple Sclerosis Introduction
12.4.4 Biogen Revenue in Multiple Sclerosis Business (2014-2019)
12.4.5 Biogen Recent Development
12.5 Genzyme (Sanofi)
12.5.1 Genzyme (Sanofi) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Multiple Sclerosis Introduction
12.5.4 Genzyme (Sanofi) Revenue in Multiple Sclerosis Business (2014-2019)
12.5.5 Genzyme (Sanofi) Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Details
12.6.2 Company Description and Business Overview
12.6.3 Multiple Sclerosis Introduction
12.6.4 GlaxoSmithKline Revenue in Multiple Sclerosis Business (2014-2019)
12.6.5 GlaxoSmithKline Recent Development
12.7 Merck Serono
12.7.1 Merck Serono Company Details
12.7.2 Company Description and Business Overview
12.7.3 Multiple Sclerosis Introduction
12.7.4 Merck Serono Revenue in Multiple Sclerosis Business (2014-2019)
12.7.5 Merck Serono Recent Development
12.8 Novartis
12.8.1 Novartis Company Details
12.8.2 Company Description and Business Overview
12.8.3 Multiple Sclerosis Introduction
12.8.4 Novartis Revenue in Multiple Sclerosis Business (2014-2019)
12.8.5 Novartis Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Multiple Sclerosis Introduction
12.9.4 Pfizer Revenue in Multiple Sclerosis Business (2014-2019)
12.9.5 Pfizer Recent Development
12.10 Teva
12.10.1 Teva Company Details
12.10.2 Company Description and Business Overview
12.10.3 Multiple Sclerosis Introduction
12.10.4 Teva Revenue in Multiple Sclerosis Business (2014-2019)
12.10.5 Teva Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Multiple Sclerosis Key Market Segments
Table Key Players Multiple Sclerosis Covered
Table Global Multiple Sclerosis Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Multiple Sclerosis Market Size Market Share by Type 2014-2025
Figure Injectable agents Figures
Table Key Players of Injectable agents
Figure Oral agents Figures
Table Key Players of Oral agents
Table Global Multiple Sclerosis Market Size Growth by Application 2014-2025 (Million US$)
Figure Hosptial Case Studies
Figure Research Case Studies
Figure Multiple Sclerosis Report Years Considered
Table Global Multiple Sclerosis Market Size 2014-2025 (Million US$)
Figure Global Multiple Sclerosis Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Multiple Sclerosis Market Size by Regions 2014-2025 (Million US$)
Table Global Multiple Sclerosis Market Size by Regions 2014-2019 (Million US$)
Table Global Multiple Sclerosis Market Share by Regions 2014-2019
Figure Global Multiple Sclerosis Market Share by Regions 2014-2019
Figure Global Multiple Sclerosis Market Share by Regions 2019
Table Market Top Trends
Table Global Multiple Sclerosis Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Multiple Sclerosis Market Share by Manufacturers (2014-2019)
Figure Global Multiple Sclerosis Market Share by Manufacturers in 2018
Table Global Multiple Sclerosis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Multiple Sclerosis Product/Solution/Service
Table Date of Enter into Multiple Sclerosis Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table Global Multiple Sclerosis Market Size Share by Type (2014-2019)
Figure Global Multiple Sclerosis Market Size Market Share by Type (2014-2019)
Table Global Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table Global Multiple Sclerosis Market Size Share by Application (2014-2019)
Figure Global Multiple Sclerosis Market Size Market Share by Application (2014-2019)
Figure Global Multiple Sclerosis Revenue Market Share by Application in 2018
Figure United States Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table United States Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table United States Key Players Multiple Sclerosis Market Share (2018-2019)
Table United States Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table United States Multiple Sclerosis Market Share by Type (2014-2019)
Table United States Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table United States Multiple Sclerosis Market Share by Application (2014-2019)
Figure Europe Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table Europe Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table Europe Key Players Multiple Sclerosis Market Share (2018-2019)
Table Europe Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table Europe Multiple Sclerosis Market Share by Type (2014-2019)
Table Europe Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table Europe Multiple Sclerosis Market Share by Application (2014-2019)
Figure China Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table China Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table China Key Players Multiple Sclerosis Market Share (2018-2019)
Table China Multiple Sclerosis Market Size by Type (2014-20189) (Million US$)
Table China Multiple Sclerosis Market Share by Type (2014-2019)
Table China Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table China Multiple Sclerosis Market Share by Application (2014-2019)
Figure Japan Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table Japan Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table Japan Key Players Multiple Sclerosis Market Share (2018-2019)
Table Japan Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table Japan Multiple Sclerosis Market Share by Type (2014-2019)
Table Japan Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table Japan Multiple Sclerosis Market Share by Application (2014-2019)
Figure Southeast Asia Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Multiple Sclerosis Market Share (2018-2019)
Table Southeast Asia Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Multiple Sclerosis Market Share by Type (2014-2019)
Table Southeast Asia Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Multiple Sclerosis Market Share by Application (2014-2019)
Figure India Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table India Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table India Key Players Multiple Sclerosis Market Share (2018-2019)
Table India Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table India Multiple Sclerosis Market Share by Type (2014-2019)
Table India Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table India Multiple Sclerosis Market Share by Application (2014-2019)
Figure Central & South America Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Multiple Sclerosis Market Share (2018-2019)
Table Central & South America Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table Central & South America Multiple Sclerosis Market Share by Type (2014-2019)
Table Central & South America Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table Central & South America Multiple Sclerosis Market Share by Application (2014-2019)
Table Abbvie Company Details
Table Abbvie Revenue in Multiple Sclerosis Business (2014-2019) (Million US$)
Figure Abbvie Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Abbvie Recent Development
Table Acorda Therapeutics Company Details
Table Acorda Therapeutics Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Acorda Therapeutics Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Acorda Therapeutics Recent Development
Table Bayer HealthCare Company Details
Table Bayer HealthCare Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Bayer HealthCare Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Bayer HealthCare Recent Development
Table Biogen Company Details
Table Biogen Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Biogen Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Biogen Recent Development
Table Genzyme (Sanofi) Company Details
Table Genzyme (Sanofi) Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Genzyme (Sanofi) Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Genzyme (Sanofi) Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Serono Company Details
Table Merck Serono Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Merck Serono Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Merck Serono Recent Development
Table Novartis Company Details
Table Novartis Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Pfizer Recent Development
Table Teva Company Details
Table Teva Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Teva Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Teva Recent Development
Table Global Multiple Sclerosis Market Size by Regions (Million US$) 2019-2025
Figure Global Multiple Sclerosis Market Size Share by Regions (2019-2025)
Figure Global Multiple Sclerosis Market Size Share by Regions in 2025
Figure United States Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure Europe Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure China Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure Japan Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure India Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Table Global Multiple Sclerosis Market Size by Product (2019-2025) (Million US$)
Figure Global Multiple Sclerosis Market Size by Product (2019-2025)
Figure Global Multiple Sclerosis Market Size by Product in 2025
Table Global Multiple Sclerosis Market Size by Application (2019-2025) (Million US$)
Figure Global Multiple Sclerosis Market Size by Application (2019-2025)
Figure Global Multiple Sclerosis Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
多発性硬化症治療の世界市場：市場規模・現状・予測 Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and somet…- 多発性硬化症薬の世界市場：市場規模・現状・予測 Multiple sclerosis (MS) is a nervous system disease which affects spinal cord and the brain. MS damages the myelin sheath. Myelin sheath is a term which exemplifies that material which surrounds and protects human nerve cells. This damage blocks messages between brain and the body and leads to the s…
- 多発性硬化症向け幹細胞療法の世界市場：市場規模・現状・予測 Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
- 筋萎縮性側索硬化症（ルーゲーリッグ病）治療の世界市場：市場規模・現状・予測 Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles. It is also termed as Lou Gehrig’s disease. There are several causes behind ALS which includes gene mutation, disorganized immune resp…
- 多発性骨髄腫用るCAR T細胞療法の世界市場：市場規模・現状・予測 CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…